JSW
WST icon

Journey Strategic Wealth’s West Pharmaceutical WST Stock Holding History

Journey Strategic Wealth’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$205K Sell
818
-60
-7% -$14.9K 0.01% 760
2025
Q4 		$242K Hold
878
– – 0.01% 608
2025
Q3 		$230K Buy
+878
New +$213K 0.01% 590
2025
Q1 		– Sell
-674
Closed -$221K – 548
2024
Q4 		$221K Buy
+674
New +$212K 0.01% 435
2022
Q2 		– Sell
-491
Closed -$202K – 218
2022
Q1 		$202K Buy
+491
New +$192K 0.02% 163

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Journey Strategic Wealth's WST Position: Q1 2026 in Review

Journey Strategic Wealth reduced its West Pharmaceutical (WST) stake by 6.8% in Q1 2026, selling an estimated $14.9K and leaving 818 shares worth $205K. The position accounts for 0.01% of the portfolio, ranked #760.

Journey Strategic Wealth first reported a position in WST in Q1 2022 and has held it in 5 quarters since. The position peaked at $242K in Q4 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Journey Strategic Wealth held 818 shares of West Pharmaceutical worth $205K as of Q1 2026.
  • Journey Strategic Wealth sold 60 West Pharmaceutical shares in Q1 2026, an estimated $14.9K.
  • West Pharmaceutical made up 0.01% of Journey Strategic Wealth's portfolio in Q1 2026, its #760 holding.
  • Journey Strategic Wealth first reported a position in West Pharmaceutical in Q1 2022 and has held it in 5 quarters since.
  • Journey Strategic Wealth's West Pharmaceutical position peaked at $242K in Q4 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.